On the other hand, severe infections and sepsis episodes may reshape the CD8+ T cell compartment and its epigenetic “imprinting” in patients with cancer, thereby influencing subsequent responses and toxicity profiles to immunotherapies. This evidence concerns the gene CD8A and infection.